Vimarsana
Biggest News Aggregation in the World

Page 11 - Aldx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aldx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aldx Today - Breaking & Trending Today

Stella Diagnostics, Inc.: Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX) - Vimarsana News

Stella Diagnostics, Inc.: Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX)

Stella Diagnostics, Inc.: Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX) SALT LAKE CITY, UT / ACCESSWIRE / April 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that its corporate name change from "JMP Properties, Inc." to "Stella Diagnostics, Inc." became effective on April 16, 2021. In connection with the name change, the Company's common stock will begin trading on the OTC Markets under the ticker symbol "SLDX" at the open of market trading on April 16, 2021. "Stella Diagnostics was founded to impro...

ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data - Vimarsana News

ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data

ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data BEIJING (dpa-AFX) - Today's Daily Dose brings you news about Alnylam's transthyretin-mediated (ATTR) amyloidosis trial results; Sarepta's mixed results of investigational gene therapy SRP-9001 in patients with Duchenne muscular dystrophy; Aldeyra's dry eye disease trial results; and Revance's anticipated milestones. Read on. 1. Aldeyra Catches Investor's Eye Aldeyra Therapeutics Inc.'s (ALDX) run-in cohort of phase III trial of Reproxalap in patients with dry eye disease has achieved statistical significance for ocul...